# CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase

> **NCT04086147** · PHASE2 · COMPLETED · sponsor: **Huashan Hospital** · enrollment: 86 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Low dose tenecteplase
- **DRUG:** High dose tenecteplase

## Key facts

- **NCT ID:** NCT04086147
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-09
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086147, "CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04086147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*